Reduction of the Dietary Glycemic Index (GI) by L-Arabinose and Indigestible Dextrin

Effects of the Combination of L-Arabinose and Indigestible Dextrin on Glycemic Index: a Double-Blind, Crossover Trial

This study aims to investigate the effect of supplement containing L-arabinose and indigestible dextrin on dietary glycemic index.

Inclusion Criteria:

• Healthy as based on medical history and physical examination
• BMI is less or equal to 30 kg/m2
• Willing not to serve as blood donor during the study
• Informed consent signed

Exclusion Criteria:

• Impaired Glucose Tolerance
• Female subjects who are pregnant or nursing a child
• Participation in any clinical trial up to 90 days before Day 1 of this study
• Renal or hepatic dysfunction
• Heart disease
• Under medication